相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Involvement of Intracellular and Extracellular High-Mobility Group Box-1 in the Progression of Esophageal Squamous Cell Carcinoma
Daiki Matsubara et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
A novel proangiogenic B cell subset is increased in cancer and chronic inflammation
Willem van de Veen et al.
SCIENCE ADVANCES (2020)
The Anti-inflammatory Effects of HMGB1 Blockades in a Mouse Model of Cutaneous Vasculitis
Jin Wang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment
Yingxia Zheng et al.
NATURE COMMUNICATIONS (2020)
FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma
Ying Wang et al.
THERANOSTICS (2020)
High mobility group box 1 promotes radioresistance in esophageal squamous cell carcinoma cell lines by modulating autophagy
Hongbing Ma et al.
CELL DEATH & DISEASE (2019)
Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1+ TAM expansion
Bin Li et al.
ONCOGENESIS (2019)
Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells
Yu Mao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8+ T cells
Kamila Hladikova et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma
Axel Lechner et al.
ONCOIMMUNOLOGY (2019)
Immunoscore for (colorectal) cancer precision medicine
Shuji Ogino et al.
LANCET (2018)
High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells
Ulf Andersson et al.
SEMINARS IN IMMUNOLOGY (2018)
Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1(+) regulatory B cell expansion
Linsen Ye et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Involvement of high mobility group box-1 in imiquimod-induced psoriasis-like mice model
Tao Chen et al.
JOURNAL OF DERMATOLOGY (2017)
CD4+ T Cell Activation and Vascular Normalization: Two Sides of the Same Coin?
Michele De Palma et al.
IMMUNITY (2017)
HMGB1 promotes myeloid-derived suppressor cells and renal cell carcinoma immune escape
Jinfeng Li et al.
ONCOTARGET (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
B cell regulation in cancer and anti-Xtumor immunity
Anushruti Sarvaria et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Trainable Weka Segmentation: a machine learning tool for microscopy pixel classification
Ignacio Arganda-Carreras et al.
BIOINFORMATICS (2017)
Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis
Shuzhen Chen et al.
CANCER LETTERS (2017)
Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer
David R. Kroeger et al.
CLINICAL CANCER RESEARCH (2016)
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
Bernhard Mlecnik et al.
IMMUNITY (2016)
Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients
Amos Kirilovsky et al.
INTERNATIONAL IMMUNOLOGY (2016)
IL-17A promotes migration and tumor killing capability of B cells in esophageal squamous cell carcinoma
Lin Lu et al.
ONCOTARGET (2016)
B Lymphocytes and Cancer: A Love-Hate Relationship
Grace J. Yuen et al.
TRENDS IN CANCER (2016)
High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule
Huan Yang et al.
MOLECULAR MEDICINE (2015)
The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment
Thomas F. Gajewski
SEMINARS IN ONCOLOGY (2015)
Intertwined regulation of angiogenesis and immunity by myeloid cells
Lee B. Rivera et al.
TRENDS IN IMMUNOLOGY (2015)
Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer
Claire Germain et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Role of extracellular membrane vesicles in intercellular communication of the tumour microenvironment
Katrin J. Svensson et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
HMGB1 Levels Are Increased in Patients with Juvenile Idiopathic Arthritis, Correlate with Early Onset of Disease, and Are Independent of Disease Duration
Hanna Schierbeck et al.
JOURNAL OF RHEUMATOLOGY (2013)
B Cells Promote Tumor Progression via STAT3 Regulated-Angiogenesis
Chunmei Yang et al.
PLOS ONE (2013)
High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases
Wei Yan et al.
HEPATOLOGY (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The Expression of High Mobility Group Box 1 is Associated with Lymph Node Metastasis and Poor Prognosis in Esophageal Squamous Cell Carcinoma
Chen Chuangui et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
Diagnostic Significance of Serum HMGB1 in Colorectal Carcinomas
Hanna Lee et al.
PLOS ONE (2012)
Systemic Toll-Like Receptor Ligands Modify B-cell Responses in Human Inflammatory Bowel Disease
Marie McDonnell et al.
INFLAMMATORY BOWEL DISEASES (2011)
Knockdown of HMGB1 in Tumor Cells Attenuates Their Ability To Induce Regulatory T Cells and Uncovers Naturally Acquired CD8 T Cell-Dependent Antitumor Immunity
Zuqiang Liu et al.
JOURNAL OF IMMUNOLOGY (2011)
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
Katrin M. Sjoquist et al.
LANCET ONCOLOGY (2011)
High-Mobility Group Box 1 Expressions in Hypoxia-Induced Damaged Mouse Islets
T. Itoh et al.
TRANSPLANTATION PROCEEDINGS (2011)
Angiogenesis
Donald R. Senger et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
HMGB1 and RAGE in Inflammation and Cancer
Gary P. Sims et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
RAGE-independent autoreactive B cell activation in response to chromatin and HMGB1/DNA immune complexes
Ana M. Avalos et al.
AUTOIMMUNITY (2010)
High-mobility group box 1 and cancer
Daolin Tang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma
Xingjun Yao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer
Hye Won Chung et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis
Takashi Hamada et al.
ARTHRITIS AND RHEUMATISM (2008)
Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma
B. -Q. Cheng et al.
DIGESTIVE AND LIVER DISEASE (2008)
Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE
Jane Tian et al.
NATURE IMMUNOLOGY (2007)
Immunologic parameters as significant prognostic factors in lung cancer
H Nakamura et al.
LUNG CANCER (2002)
Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer
H Kuniyasu et al.
JOURNAL OF PATHOLOGY (2002)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
分享论文
